<DOC>
	<DOC>NCT00891371</DOC>
	<brief_summary>The purpose of this study, is to assess the effect of lanreotide Autogel 120mg on stool frequency in subjects with refractory diarrhea at day 28 (mean of last 7 days) compared to baseline.</brief_summary>
	<brief_title>Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Lanreotide</mesh_term>
	<mesh_term>Angiopeptin</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Male/female with refractory diarrhea for at least 1 month, after normal extended workup to exclude causes of diarrhea, not or not enough responding to standard antidiuretics as evaluated by the investigator Patient mentally fit for completing a diary Has already received a treatment with somatostatin analogues for the treatment of refractory diarrhea Had a weight of stool &lt; 600g in a 72hrs stool collection Has received a treatment with laxatives within the last week before study entry Suffers from IBS with alternating bowel habits and predominant constipation, suffers from infectious and/or inflammatory gastroenteritis (colitis ulcerosa, crohn's disease and macroscopic colitis)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>symptomatic treatment of patients with refractory diarrhea</keyword>
</DOC>